Starpharma Holdings LimitedASX: SPL

Positive final DEP irinotecan Phase 2 clinical trial results

May 27, 2024 at 4:36 AM UTC · Issued by Starpharma Holdings Limited

Starpharma Holdings Ltd has released a press release.

View Attachment